Delhi is recording a high spike in Covid-19 cases and has reported 28,395 new cases in the last 24 hours.
Total cases: 9,05,541
Total discharges: 8,07,328
Active cases: 85,575
Death toll: 12,638
PM Modi interacted with vaccine manufacturers of the country on Tuesday via video conferencing and requested them to continuously scale up the production capacity to vaccinate people in the shortest possible time.
ANI reported that the PM applauded the vaccine manufacturers for their achievements and professionalism and said the biggest strength of country’s vaccine industry is its ‘Samarthya, Sansadhan and Seva Bhaav’ and these attributes makes them a vaccine leader in the world.
He said that the government has now allowed the vaccinated programme for every adult starting May 1 believing in the ability of the vaccine manufacturers.
According to a PMO release, he also appreciated the efforts and studies bring conducted by scientists in development of new vaccines.
He said the government ensured that all the vaccine manufacturers not only get all possible help and logistics support, but also assured that all possible support and smooth approval process for the vaccine candidates which are currently under trial phase.
Dakshina Kannada Deputy Commissioner KV Rajendra has warned private hospitals of medical negligence case if they refuse to admit COVID patients or transfer them to another facility without any valid reasons further seeking to deliver the test reports of COVID suspects within two days of collecting the samples.
Also the instructions have been given to private facilities regarding the number of beds and the charges incurred per COVID test.
Explaining the new directions at a Covid-19 management coordination meeting, Dr Rajendra stated that some of the private hospitals take too much time to give the report of COVID test, and often the test reports arrive after one week. Under such circumstances, there remains a high chance of transmission of the of the disease. Hence, he instructed the hospitals to ensure that COVID test reports are delivered within two days so that the patient can be immediately isolated as per the standard protocols.
He also suggested that 50 per cent of the beds in private hospitals should be reserved for COVID patients. He has also instructed the hospitals not to deny admission to any COVID patient and if any such case comes forth, medical negligence case can be lodged against the hospital.
Moreover, the hospitals are allowed to charge only upto Rs. 800 over per COVID 19 test. The price cap should be strictly followed and the hospitals are barred from incurring any additional amount for COVID testing.
The United States will soon have oral drugs for the treatment of the new coronavirus. Patients suffering from the new coronavirus will take the drug at home for 5 days, the new coronavirus will be completely eliminated from the body and the patient will fully recover.
The drug, translated as “Molnupiravir” was jointly developed by two major pharmaceutical companies, “Rigibel” in Germany and “Merck” in the United States, and has successfully completed the first and second phases of clinical trials in humans. The effect is 100%; the current phase 3 clinical trial is nearing the end and the effect is very good. If it goes well, it will be available in the market within 4 to 5 months.
The patient can take the drug by himself at home, and heal in 5 days, which is very convenient to use. Treating the new coronavirus in the future is like treating the common cold now. The new coronavirus is not terrible.
The drug was originally developed against influenza viruses. It is a compound, the principle is to prevent the virus ia enzyme, that is, to prevent the virus itself from replicating, so as to eliminate the virus quickly. The principle of the current anti-coronavirus vaccine is to target the flange of the new coronavirus, thereby preventing the combination of the new coronavirus and human cells. The principles of the two are different.
From March to April last year, a new coronavirus occurred in mink farms in the Netherlands and Norway, resulting in the massive death of millions of minks. The mink farm fed the mink with “Monapinavir” and found that there was no new coronavirus in the sick mink 24 hours later. The mink farm quickly stopped the spread of the new coronavirus. Then the two major pharmaceutical companies will carry out the first phase of clinical trials on humans. After success, they will conduct the second and third phases of clinical trials. So far, they will be officially launched.
This is a great achievement in the scientific community, especially in the medical community. Perhaps it will follow Valium, aspirin and penicillin, and Apin is the four classic drugs.
India’s daily new cases are showing a rising trend with over 2.5 Lakh new cases reported in the last 24 hours.
New cases: 2,59,170
Inoculations in last 24 hours: 32,76,555
Total number of vaccines given till now: 12,71,29,113
Deaths in last 24 hours: 1,761
AstraZeneca and University of Oxford are working on modification of the existing Covid-19 vaccine Covishield in India to become effective against the South African coronavirus.
AstraZeneca’s Austria country manager, Sarah Walters said in an interview that the vaccine is expected to be ready by the end of the year.
Amid covid case surge in India, the Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said there is no difference between the first wave and the second wave.
He said that 70% of the infected patients are above 40 years of age in the both waves.
“Higher requirement of oxygen was found in this wave. There is no difference in the percent of death between the first wave and second wave from the data we have,” said ICMR DG Dr. Balram Bhargava, ANI reports.
He further said that the holed up population continues to be more vulnerable to be admitted to the hospital and have problems.
“If you see the symptoms, severity is very less this time. In this wave, we have witnessed more cases of breathlessness while in the last wave, symptoms like dry cough, joint pain, headaches were more,” Bhargava said.
Accoding to the DG ICMR listed three main reasons for the higher transmissibility of Covid-19 – laxity, Covid inappropriate behavior and and various unidentified mutation.
“We have had tremendous amount of laxity , the Covid-19 appropriate behavior and various unidentified mutation, of them some are of concern —UK, Brazilian and South African variants, which have been demonstrated to have higher transmissibility,” said Dr. Balram Bhargava.
“We have also found a double mutant in India but the higher transmissibility of this is not established.” he added
British Health officials are investigating Covid-19 variant originating in India but as yet they have enough evidence to classify it is as a variant of concern, Susan Hopkins of Public Health England (PHE) said on Sunday.
PHE has said it has identified 77 cases of the variant in Britain.
Madhya Pradesh: A hospital ward boy hospital tried to rape a 50-year-old patient admitted at a COVID care centre set up in a hotel in Gwalior on Saturday, police said.
The victim told that the ward boy tried to sexually assault her twice during the intervening night of Saturday and Sunday but fled after her family members raised an alarm, Additional Superintendent of Police (ASP) Hitika Vasal said.
The victim’s brother-in-law alleged the hospital staff had helped the ward boy flee.
The ward boy has been arrested and a case has been registered at Kampu police station.